Skip to the page

Data / Federal grants / HT942526JWMRPMMRDA

DoW Joint Warfighter Medical, Military Medical Research and Development Award

Defense Health Agency Contracting Activity - DHACA (Department of Defense) is accepting applications until November 16, 2026. It lists 4 awards expected, $8.8 million in total.

SpecStream is the live web data engine for teams and agents. It reads every open and forecast federal opportunity on Grants.gov each morning, and this page is that reading. Describe your organization once and the grants that fit arrive in your sheet, CRM, Slack or agent as they are posted.

Key facts

Opportunity number
HT942526JWMRPMMRDA
Status
Posted, open
Posted
June 17, 2026
Closes
November 16, 2026
Expected awards
4
Total funding
$8,800,000
Cost sharing
Not required
Funding instrument
Cooperative Agreement, Grant, Other, Procurement Contract
Category
Science and Technology and other Research and Development
Assistance listing
12.420 Military Medical Research and Development
Contact
Christopher L Baker Grants Officer · [email protected] · 3016192332

Who can apply

  • Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

What the agency says

Summary: The fiscal year 2026 (FY26) Joint Warfighter Medical Research Program (JWMRP) Military Medical Research and Development Award (MMRDA) mechanism is intended to fund the logical continuation of previous Department of War (DOW)-funded research and development efforts relevant to the FY26 JWMRP that augment and accelerate high-priority medical requirements to meet the needs of Service Members and other Military Health System beneficiaries. The MMRDA supports a wide range of research projects spanning late-stage preclinical studies, late-state technology development efforts, technology demonstration, translational, and clinical research. Projects must be relevant to at least one of the FY26 JWMRP focus areas.

Distinctive Features:

To be eligible for JWMRP funding, applicants/offerors must have already received DOD/DOW core or DOD/DOW Congressional Special Interest funding.

An MMRDA Clinical Research or Clinical Trial Option (MMRDA-CRCTO) is available to specifically support clinical research/observational studies, all phases of clinical trials/interventional studies, and/or correlative studies in support of the development of promising pharmaceutical or biologic candidates, medical devices and technologies. Applicants/offerors should select MMRDA-CRCTO when the application/proposal involves research that includes any human subjects, human biological samples (prospective or retrospective) or human data sets. Note: If selecting this option, applicants must submit additional relevant application/proposal materials.

The notice on Grants.gov

Other open grants from the Department of Defense

All grants open to Anyone (unrestricted) · Everything closing in November 2026

Read from the Grants.gov API, last updated 2026-10-23. The agency's notice on Grants.gov is the official record; check it before you apply.